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Cognitive-behavioral therapy for bulimia nervosa and atypical bulimic nervosa: 
Effectiveness in clinical settings 
 
Abstract 
Objective: The efficacy of cognitive-behavioral therapy (CBT) for bulimic disorders has 
been established in research trials. This study examined whether that efficacy can be 
translated into effectiveness in routine clinical practice. 
Method: Seventy-eight adult women with bulimic disorders (bulimia nervosa; atypical 
bulimia nervosa) undertook individual CBT, with few exclusion criteria and a treatment 
protocol based on evidence-based approaches, utilizing individualized formulations. Patients 
completed measures of eating behaviors, eating attitudes, and depression pre- and post-
treatment. Eight patients dropped out. The mean number of sessions attended was 19.2. 
Results: No pretreatment features predicted drop-out. Treatment outcome was similar 
whether using treatment completer or intent to treat analyses. Approximately 50% of 
patients were in remission by the end of treatment. There were significant improvements in 
mood, eating attitudes and eating behaviors. Reductions in bingeing and vomiting were 
comparable to efficacy trials. 
Discussion: 7KH LPSURYHPHQWV LQ WKLV µUHDO-ZRUOG¶ WULDO RI &%7 IRU DGXOWV ZLWK EXOLPLF
disorders mirrored those from large, funded research trials, though the conclusions that can 
be reached are inevitably limited by the nature of the trial (e.g., lack of control group and 
therapy validation).  
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Cognitive-behavioral therapy for bulimia nervosa and atypical bulimic nervosa: 
Effectiveness in clinical settings 
 There is substantial evidence that cognitive-behavioral therapy (CBT) is efficacious 
in the treatment of adult women with bulimia nervosa and atypical bulimic disorders (1-7). 
However, that evidence has come from funded research studies. Such findings are not 
necessarily generalizable to the wider range of clinical settings, due to factors such as the 
exclusion of comorbidity or atypical cases, treatment being delivered under highly stringent 
conditions, and the need to adhere strictly to protocols. Thus, such evidence of efficacy in 
the research environment needs to be translated into evidence of effectiveness in less 
specialized clinical practice, in order to avoid clinicians ignoring the evidence as being 
irrelevant to their client group (8). This attitude might explain the common omission of core 
techniques when delivering CBT for adults with eating disorders (9) and the fact that only a 
minority of clinicians report using manuals when working with bulimia nervosa (10). There is 
evidence for the clinical applicability of research-based CBT for anxiety and depression (11-
12). However, that is not the case in the eating disorders. Therefore, this study considered 
whether the efficacy of CBT for bulimic disorders (as shown by existing research trials) can 
be translated into clinical effectiveness in routine clinical settings, where none of the 
exclusion- and protocol-based constraints outlined above apply.  
Method 
Participants 
 All patients were treated in a publically-funded outpatient eating disorder service in 
the UK. The only exclusion criteria were psychosis, learning difficulties, or an inability to 
work in English. The participants in the trial were a case series of those patients with bulimic 
disorders who opted to undertake CBT when assessed and when treatment options were 
discussed. A small number of patients opted to undertake a psychodynamic therapy, while 
another group attended for assessment but declined or failed to attend for treatment. 
However, the numbers in these groups were not recorded. Therefore, this is a study of those 
who opted to begin CBT, rather than all who attended the clinic or who had bulimic 
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disorders. None were excluded from the trial due to missing data (see below). 
The sample entering treatment were 78 adult women with bulimic disorders - 55 with 
bulimia nervosa (52 purging subtype; three non-purging subtype) and 23 with EDNOS 
involving bulimic behaviors (nine with subthreshold bulimia nervosa, involving bingeing and 
purging at least once per week over three months; ten with binge eating disorder; and four 
with purging in the absence of bingeing). None were in the anorexic weight range. All were 
assessed using a semi-structured interview protocol (13), and diagnosed using DSM-IV 
criteria (14). The mean age of the sample at assessment was 27.8 years (SD = 7.11) and 
their mean body mass index (BMI) was 22.1 (SD = 3.26).  
A minority of the bulimic sample (N = 9) were receiving SSRI antidepressants 
(stabilized prior to treatment and maintained throughout the treatment period) and a small 
number had occasional dietetic reviews, but none were receiving any other form of 
treatment in parallel with CBT. A high proportion had some comorbidity (major depressive 
disorder - 44% of cases; obsessive-compulsive disorder - 26%; other anxiety disorders - 
32%; substance misuse - 23%). The levels for anxiety and depressive disorders are higher 
than in some efficacy studies (3), but comparable for substance misuse. 
Measures  
 Height and weight were measured objectively. Diaries were used to assess 
frequency of bingeing and vomiting. The women also completed measures of eating 
pathology and depression at the beginning and end of treatment. 
Eating Disorders Inventory. The EDI (15) is a self-report measure of eating and 
related attitudes. Scores are responsive to changes over treatment. Scores on the eating-
related scales (Drive for thinness; Bulimia; Body dissatisfaction) were summed to provide an 
overall score reflecting eating attitudes.  
Beck Depression Inventory. The BDI (16) is a self-report measure of depressive 
symptoms, with good psychometric properties. 
Treatment 
This version of CBT (13) is based on techniques employed in evidence-based 
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approaches to bulimia nervosa (I,2,4) , In keeping with those approaches, this programme 
includes: individualized formulation, taking into account different maintaining factors across 
cases (e.g., nutritional and/or emotional drivers for binging); agenda setting; homework; 
change in diet (particularly to improve carbohydrate intake); diary-keeping; exposure; 
behavioral experiments; cognitive restructuring; and surveys. Comorbidity was usually 
addressed once the core eating disorder symptoms were substantially reduced, unless there 
was evidence that the patient was not changing eating behaviors in the early part of CBT.  
 The clinicians were all clinical psychologists with at least four years of experience in 
delivering CBT for eating disorders, and were supervised routinely on these cases 
(individually and in groups). The usual assumption was that there would be around 20 one-
hour CBT sessions. However, this was reduced if the patient improved rapidly, and was 
increased if the patient had substantial comorbidity (such increases were reviewed by the 
team after each additional set of ten sessions). Whatever the duration, behavioral change 
was maintained as a focus, along with changes in mood and cognitions. The mean number 
of sessions delivered per patient was 19.2 (SD = 12.4; range = 7-80). Three follow-up 
sessions were offered in addition. 
Patients were regarded as in remission if they no longer had a diagnosis of any 
eating disorder by the end of treatment (including being free of bulimic behaviors for at least 
a month prior to the last session, and not having pathological concerns about eating, weight 
and shape). This latter criterion was established through clinical review. Drop-out was 
defined as the patient ending treatment before the agreed termination point (defined by 
patient and clinician), whether early or late in treatment. 
Data analysis 
Binary logistic regression was used to identify any pre-treatment factors that 
predicted drop-out (17). Change was measured in three ways ± as the proportion of patients 
ceasing individual and all bulimic behaviours (objective binge-eating, vomiting, laxative 
abuse) by the end of treatment; as the proportion of patients who changed or no longer met 
diagnostic criteria at the end of treatment (remission); and as the dimensional differences in 
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frequencies of behaviours, BMI level, eating attitudes and depression. As the data were not 
sufficiently normal, changes in symptom levels were tested using Wilcoxon tests. This final 
analysis is done as both a treatment completer analysis and an intent-to-treat analysis 
(carrying forward the most recent data to substitute for missing data where a patient 
dropped out). At the end of treatment, there were nine missing EDI scores and 12 missing 
BDI scores. These were treated as absent for the completer analysis. 
Results 
Predictors of attrition 
Eight of the 78 patients dropped out over the course of treatment. This rate is similar 
to that reported in protocol-driven research studies (3-4,18). Binary logistic regression was 
used to determine whether drop-out was related to pre-treatment age, BMI, frequency of 
bingeing or vomiting, EDI scores or BDI scores. The overall model was not significant (X2 = 
11.5, df = 6, P = .075), and no individual variable approached significance (P > .16 in all 
cases). Therefore, no identified pre-treatment variables predicted attrition from CBT. 
Cessation of bulimic behaviours following CBT 
 Among the completer group, 66 engaged in objective binging at the beginning of 
treatment, and 28 at the end of treatment (abstinent = 58%), 51 engaged in vomiting at the 
beginning and 25 at the end (abstinent = 51%), and 17 engaged in laxative abuse at the 
beginning and three at the end  (abstinent = 82%). 56% were free of all binging and pur ging 
behaviours by the end of treatment (all patients had at least one of these behaviours at the 
start of treatment). These reductions are comparable with those reported across treatment 
in clinical trials (3). 
Change in diagnosis following CBT 
 Table 1 shows shifts in diagnoses from beginning to end of CBT. Overall, 37 (52.9%) 
of the 70 patients who reached the end of treatment were diagnosis-free by that point (no 
bulimic behaviours, alongside normalised eating attitudes). Assuming no such change 
among the eight patients who had dropped out, this represents 47.4% of the 78 patients 
who started CBT. This remission rate is similar to that found in comparable research (2-4).  
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___________________________  
Insert Table 1 about here 
___________________________  
 
Diagnostic group at the outset of treatment was not broadly predictive of change in 
diagnosis. However, those with purging disorder showed a mixture of positive and negative 
outcomes, suggesting that this form of CBT is more suitable for those who binge-eat. 
Dimensional change in symptoms following CBT  
Table 2 shows changes across therapy in body mass index, frequencies of bulimic 
behaviors, eating attitudes, and depression. This is done separately for treatment 
completers (N = 70) and as an intent to treat analysis (N = 78). Regardless of the form of 
analysis, there were significant changes on all of these measures, with a small increase in 
BMI and larger reductions in objective binges, vomiting, eating attitudes and depressed 
mood. The effect sizes (tau  =¥>1@IRUWKHVHFKDQJHVYDULHGEHWZHHQPHGLXPDQGODUJHLQ
both sets of analyses. The frequency of objective bingeing fell by 59% in the treatment 
completer analysis (intent to treat - 64%), and vomiting levels fell by 72% (intent to treat - 
65%). These findings are similar to levels of change reported in the literature (7).  
___________________________  
Insert Table 2 about here 
___________________________  
 
Discussion 
 Research trials have demonstrated the efficacy of CBT for bulimic disorders. 
However, clinicians commonly regard such findings as irrelevant to their practice (8). 
Therefore, this study tested whether those findings can be translated into evidence of 
effectiveness in healthcare settings where there are few exclusion criteria and where the 
implementation of the therapy is less intensively scrutinised. It also included atypical bulimic 
cases. The findings were broadly comparable to those found in research trials - the drop-out 
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rate was low (10.3%), the remission rate was approximately 50%, and there were 
substantial reductions in levels of pathological eating attitudes and depression. In short, 
these findings demonstrate that this form of CBT for bulimia nervosa (13) is effective in 
treating the eating disorders in µUHDO-OLIH¶FOLQLFDOVHWWLQJV+RZHYHULWLVLPSRUWDQWWRQRWHWKDW
these results were achieved by clinicians within a specialist eating disorder clinic, who had 
relatively high levels of training, experience and supervision. Its effectiveness in other 
settings or as delivered by less experienced clinicians remains to be demonstrated. It is also 
necessary to note that this was an uncontrolled trial, with no validation checks (beyond 
routine supervision) to confirm that the therapy delivered actually was CBT. While these 
features are inevitable consequences of delivering treatments in real life settings, they limit 
the strength of any conclusions that can be reached regarding the effectiveness of CBT. 
 Several forms of CBT for adults with eating disorders have been shown to be 
efficacious to a comparable degree in research settings (1-4). Each shares themes with the 
form used here - particularly the foci on individualized formulation, exposure, behavioral 
change, recording, and cognitive restructuring. Therefore, these findings suggest that other 
evidence-based forms of CBT for the bulimic disorders might have similar levels of 
effectiveness in purely clinical settings, although the lack of a control group in studies of this 
sort makes it impossible to conclude definitively that it is elements of CBT that are 
responsible for  the positive outcomes seen. Clinicians could be encouraged to use existing 
manualized forms of CBT for bulimia nervosa more than they currently do (9-10), on the 
grounds that these relatively structured forms of treatment for the eating disorders can be as 
effective in everyday clinical settings as they are efficacious in research settings. Further 
work is needed to determine whether these effects are maintained in the long term, as they 
are in research trials. Such research would also benefit from a wider range of measures of 
eating pathology (e.g., body image, other purging behaviours), as the measures used here 
were relatively crude, and might have omitted key indices of change. It should also consider 
the potential role of factors such as duration of disorder, previous treatment experiences, 
and socio-economic status, to allow for comparison with existing and future clinical trials. 
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Finally, it will be important to determine whether the efficacies of other therapies for bulimic 
disorders (e.g., interpersonal psychotherapy; dialectical behavior therapy) are matched by 
their effectiveness. 
 
Note 
The authors have received no financial support for this work, and have no conflict of interest. 
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Table 1 
Diagnostic outcomes at end of treatment, among those completing CBT (N = 70) 
 
 
 Diagnostic group at end of treatment 
  
No eating 
disorder 
 
Bulimia nervosa 
  
EDNOS 
 
Diagnostic group at 
beginning of treatment 
 
Purging 
subtype 
 
Non-purging 
subtype  
 
Atypical bulimia 
nervosa 
 
Binge eating 
disorder 
 
Purging 
disorder 
Bulimia nervosa 
       Purging subtype (N = 46) 
 
22  (47.8%) 
 
22  (47.8%) 
 
0 
 
2  (4.3%) 
 
0 
 
0 
       Non-purging subtype (N = 1) 1  (100%) 0 0 0 0 0 
EDNOS 
       Atypical bulimia nervosa (N = 9) 
 
5  (55.6%) 
 
0 
 
0 
 
4  (44.4%) 
 
0 
 
0 
       Binge eating disorder (N = 10) 8  (80.0%) 0 0 0 2  (20.0%) 0 
       Purging disorder (N = 4) 1  (25.0%) 0 1  (25.0%) 1  (25.0%) 0 1  (25.0%) 
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Table 2 
Symptom change across treatment among those completing CBT (N = 70) and using intent-to-treat analysis (N = 78) 
 
Type of analysis 
 
Treatment completers 
   
Intent-to-treat 
 
 
Point in treatment 
 
Beginning of 
treatment 
 
End of 
treatment 
 
Wilcoxon test 
 
Effect 
size 
tau 
  
Beginning of 
treatment 
 
End of treatment 
 
Wilcoxon test 
Effect 
size 
tau 
 Mean (SD) Mean (SD) Z P  Mean (SD) Mean (SD) Z P 
Symptom a 
Body mass index 
 
22.8 
 
(3.58) 
 
23.3 
 
(3.80) 
 
2.98 
 
.003 
 
0.36 
  
22.1 
 
(3.26) 
 
22.8 
 
(3.67) 
 
3.61 
 
.001 
 
0.41 
Objective binges per week 4.45 (6.51) 1.84 (5.07) 3.25 .001 0.39  5.51 (9.65) 1.98 (4.86) 4.93 .001 0.56 
Vomiting per week 5.31 (7.96) 1.49 (3.28) 2.93 .003 0.35  6.88 (10.1) 2.41 (5.29) 2.83 .005 0.32 
Eating Disorders Inventory 46.0 (15.4) 26.3 (21.0) 2.39 .02 0.29  37.6 (21.8) 24.1 (22.5) 2.58 .01 0.29 
Beck Depression Inventory 22.7 (9.95) 12.2 (11.0) 4.78 .001 0.57  21.9 (9.46) 12.1 (10.5) 4.59 .001 0.52 
 
a
  No missing data for body mass index, objective binges or vomiting episodes, and no missing start of treatment data for other variables. 
Missing data for Eating Disorders Inventory and Beck Depression Inventory mean that completer N = 61 and 58, respectively. 
 
